NCT07026097 Online Versus Physically Supervised Pilates Exercise Program in Non-specific Low Back Pain
| NCT ID | NCT07026097 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-01 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will be Randomized Controlled Trial and will be conducted in Riphah Rehabilitation Research Center. The study duration will be 9 months. Non- probability convenient sampling technique will be used to collect the data. Patients with chronic non-specific low back pain will be included in this study after meeting the inclusion criteria. The sample size of this study is 40 participants 20 in each group. Both groups will be an experimental group and will receive Pilates exercise protocol and common standard physical therapy treatment, 02 times a week for 04 weeks. Group A will receive supervised online Pilates exercise plan with common standard physical therapy and Group B will receive clinical supervised Pilates with common standard physical therapy treatment. The common standard physical therapy plan will be a hot pack for lumbar region for 10 mins, hamstring stretch, participants should maintain this stretch for 30 secs with 10 repetitions and strengthening of abdominal muscles in crook lying position with 10 repetitions with hold of 30 sec. The Pilates exercise protocol will include rollup, one leg circle exercise, crook leg lying, prone single leg kick, side-lying clamshell, supine stretch exercise, bug roll, prone attitude rotation, side kick and saw exercise. The Pilates protocol will be of 30 mins with 06-10 repetitions for each exercise withhold time for 30 sec. The outcome measure will be Numeric Pain Rating Scale (NPRS) for pain, Oswestry Low Back Disability Questionnaire (ODI) for disability and inclinometer for range of motion.
Eligibility Criteria
Inclusion Criteria: * Patients with LBP * Minimum chronicity of LBP 03 * Both Gender * Age ranges from 18-40 * Numeric pain rating scale (NPRS) score 3 to 8 for pain intensity * Patient who can maintain their standing posture independently for ≥30 minutes, have enough physical autonomy to participate in the physical activities required by the study * Oswestry Disability Index score 20-34 Exclusion Criteria: * History of trauma or fracture of the supine * Chronic systemic soft tissue or bony disease * Post Operative * Pregnancy * Diagnosis of osteoarthritis and herniated disc * Any medical red flags * Neurological and visual impairments * Presence of root symptoms (e-g sciatica and cauda equina syndrome)
Contact & Investigator
Syed Shakil ur Rehman, PhD
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07026097 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07026097 currently recruiting?
Yes, NCT07026097 is actively recruiting participants. Contact the research team at shakil.urrehman@riphah.edu.pk for enrollment information.
Where is the NCT07026097 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07026097 clinical trial?
NCT07026097 is sponsored by Riphah International University. The principal investigator is Syed Shakil ur Rehman, PhD at Riphah International University. The trial plans to enroll 40 participants.